Cargando…
Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
BACKGROUND: Newcastle disease is a devastating disease in poultry caused by virulent Newcastle disease virus (NDV), a paramyxovirus endemic in many regions of the world despite intensive vaccination. Phylogenetic analyses reveal ongoing evolution of the predominant circulating genotype 2.VII, and th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072307/ https://www.ncbi.nlm.nih.gov/pubmed/33902633 http://dx.doi.org/10.1186/s12985-021-01540-0 |
_version_ | 1783683891732676608 |
---|---|
author | Moharam, Ibrahim Asala, Olayinka Reiche, Sven Hafez, Hafez Beer, Martin Harder, Timm Grund, Christian |
author_facet | Moharam, Ibrahim Asala, Olayinka Reiche, Sven Hafez, Hafez Beer, Martin Harder, Timm Grund, Christian |
author_sort | Moharam, Ibrahim |
collection | PubMed |
description | BACKGROUND: Newcastle disease is a devastating disease in poultry caused by virulent Newcastle disease virus (NDV), a paramyxovirus endemic in many regions of the world despite intensive vaccination. Phylogenetic analyses reveal ongoing evolution of the predominant circulating genotype 2.VII, and the relevance of potential antigenic drift is under discussion. To investigate variation within neutralization-sensitive epitopes within the protein responsible for receptor binding, i.e. the Hemagglutinin-Neuraminidase (HN) spike protein, we were interested in establishing genotype-specific monoclonal antibodies (MAbs). METHODS: An HN-enriched fraction of a gradient-purified NDV genotype 2.VII was prepared and successfully employed to induce antibodies in BalbC mice that recognize conformationally intact sites reactive by haemagglutination inhibition (HI). For subsequent screening of mouse hybridoma cultures, an NDV-ELISA was established that utilizes Concanavalin A (ConA-ELISA) coupled glycoproteins proven to present conformation-dependent epitopes. RESULTS: Six out of nine selected MAbs were able to block receptor binding as demonstrated by HI activity. One MAb recognized an epitope only present in the homologue virus, while four other MAbs showed weak reactivity to selected other genotypes. On the other hand, one broadly cross-reacting MAb reacted with all genotypes tested and resembled the reactivity profile of genotype-specific polyclonal antibody preparations that point to minor antigenic differences between tested NDV genotpyes. CONCLUSIONS: These results point to the concurrent presence of variable and conserved epitopes within the HN molecule of NDV. The described protocol should help to generate MAbs against a variety of NDV strains and to enable in depth analysis of the antigenic profiles of different genotypes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-021-01540-0. |
format | Online Article Text |
id | pubmed-8072307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80723072021-04-26 Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt Moharam, Ibrahim Asala, Olayinka Reiche, Sven Hafez, Hafez Beer, Martin Harder, Timm Grund, Christian Virol J Research BACKGROUND: Newcastle disease is a devastating disease in poultry caused by virulent Newcastle disease virus (NDV), a paramyxovirus endemic in many regions of the world despite intensive vaccination. Phylogenetic analyses reveal ongoing evolution of the predominant circulating genotype 2.VII, and the relevance of potential antigenic drift is under discussion. To investigate variation within neutralization-sensitive epitopes within the protein responsible for receptor binding, i.e. the Hemagglutinin-Neuraminidase (HN) spike protein, we were interested in establishing genotype-specific monoclonal antibodies (MAbs). METHODS: An HN-enriched fraction of a gradient-purified NDV genotype 2.VII was prepared and successfully employed to induce antibodies in BalbC mice that recognize conformationally intact sites reactive by haemagglutination inhibition (HI). For subsequent screening of mouse hybridoma cultures, an NDV-ELISA was established that utilizes Concanavalin A (ConA-ELISA) coupled glycoproteins proven to present conformation-dependent epitopes. RESULTS: Six out of nine selected MAbs were able to block receptor binding as demonstrated by HI activity. One MAb recognized an epitope only present in the homologue virus, while four other MAbs showed weak reactivity to selected other genotypes. On the other hand, one broadly cross-reacting MAb reacted with all genotypes tested and resembled the reactivity profile of genotype-specific polyclonal antibody preparations that point to minor antigenic differences between tested NDV genotpyes. CONCLUSIONS: These results point to the concurrent presence of variable and conserved epitopes within the HN molecule of NDV. The described protocol should help to generate MAbs against a variety of NDV strains and to enable in depth analysis of the antigenic profiles of different genotypes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-021-01540-0. BioMed Central 2021-04-26 /pmc/articles/PMC8072307/ /pubmed/33902633 http://dx.doi.org/10.1186/s12985-021-01540-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Moharam, Ibrahim Asala, Olayinka Reiche, Sven Hafez, Hafez Beer, Martin Harder, Timm Grund, Christian Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt |
title | Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt |
title_full | Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt |
title_fullStr | Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt |
title_full_unstemmed | Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt |
title_short | Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt |
title_sort | monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for newcastle disease virus genotype 2.vii from egypt |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072307/ https://www.ncbi.nlm.nih.gov/pubmed/33902633 http://dx.doi.org/10.1186/s12985-021-01540-0 |
work_keys_str_mv | AT moharamibrahim monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt AT asalaolayinka monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt AT reichesven monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt AT hafezhafez monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt AT beermartin monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt AT hardertimm monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt AT grundchristian monoclonalantibodiesspecificforthehemagglutininneuraminidaseproteindefineneutralizingepitopesspecificfornewcastlediseasevirusgenotype2viifromegypt |